Survey reveals Biocon in top 20 Biotech employers globally

Ranking result of a global survey conducted by American Association for Advancement of Science through its affiliate Science magazine

Biocon Ltd said it has earned the distinction of being the only Asian Biopharma Company to feature among the top biotechnology employers in the world as ranked by Science magazine.

The ranking is a result of a global survey conducted by the American Association for the Advancement of Science (AAAS) through its affiliate Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally, the company said in a statement on Tuesday.

According to the comprehensive 2015 Web-based survey of more than 5,700 respondents on 23 different attributes, Biocon has been recognized for three Key Attributes which are 'Innovative leader in the industry,' 'Has loyal employees' and 'Is socially responsible' and has been positioned at No. 13.

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon said, "We are delighted to achieve this global recognition, which is an outcome of our efforts to create an inspiring workplace built on a strong foundation of an innovation-led ecosystem that attracts the best global talent. At Biocon, we have invested in creating a culture that pursues excellence through learning and adopting global best practices. In doing so, we have successfully earned the reputation of being the most preferred biotech employer in Asia."

The Top 20 companies with the best reputations as employers were shortlisted from the list of more than 181 global companies. The 2015 survey included a way for respondents to rank the biggest advantages to working in the biopharma industry. Workers voted "innovation" solidly as No. 1, followed by "working with smart colleagues" and "excellent compensation and benefits" as a close No. 2 and No. 3, respectively. Interestingly, workers ranked "having the funding and resources for research projects" as a more distant No. 4.